Form 4: Director Kare Schultz Exercises Hims & Hers RSUs

Sentiment:

Statement of Changes in Beneficial Ownership


Director Kare Schultz acquired 3,656 shares of Hims & Hers Health, Inc. through the vesting of restricted stock units.

Summary

  • Director Kare Schultz exercised 3,656 restricted stock units (RSUs) on June 11, 2026.
  • Each RSU converted into one share of Class A Common Stock.
  • Following the transaction, the reporting person holds 19,397 shares of Class A Common Stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents the standard fulfillment of director compensation agreements.

Positives

  • Director maintains a direct equity stake in the company, aligning interests with shareholders.

Negatives

  • None identified; this is a routine equity compensation settlement.

Risks

  • None identified; this is a standard administrative filing regarding equity compensation.

Future Outlook

Not applicable; this is a retrospective disclosure of an equity transaction.

Industry Context

StockSavvy.ai notes that routine RSU vesting for directors is standard corporate governance practice and does not typically signal a change in strategic direction or market sentiment.

Comparison to Industry Standards

  • The transaction follows standard equity compensation practices for public company directors.

Stakeholder Impact

  • Minimal impact on shareholders as this is a routine equity settlement.

Key Dates

DateDescription
06/11/2026Date of RSU exercise and acquisition of Class A Common Stock.
06/15/2026Date of filing signature.

Keywords

Hims & Hers, HIMS, Form 4, Insider Trading, Equity Compensation, Director Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.